EU seals deal for up to 1.8 bn extra BioNTech/Pfizer doses
The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its COVID-19 vaccine, European
Read moreThe EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its COVID-19 vaccine, European
Read moreSwiss pharma giant Roche said Monday it would pay $1.8 billion (1.5 billion euros) to buy US firm GenMark Diagnostics
Read more